191420 — Tego Science Income Statement
0.000.00%
Last trade - 00:00
- KR₩173bn
- KR₩153bn
- KR₩8bn
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,346 | 8,789 | 8,300 | 7,678 | 7,772 |
Cost of Revenue | |||||
Gross Profit | 4,715 | 6,640 | 6,403 | 5,615 | 5,304 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,138 | 7,277 | 8,398 | 7,469 | 10,102 |
Operating Profit | 208 | 1,512 | -98 | 210 | -2,330 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 864 | 2,054 | 66.2 | 202 | -2,563 |
Provision for Income Taxes | |||||
Net Income After Taxes | 832 | 1,810 | 47.5 | 256 | -2,343 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 856 | 1,831 | 139 | 265 | -2,323 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 856 | 1,831 | 139 | 265 | -2,323 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 122 | 71.3 | 17.3 | 33 | -197 |
Dividends per Share |